ArticleCancer science2023

Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD-like receptor family CARD domain-containing 5.

Asaka Wada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.